Allegro Ophthalmics is Drug Discovery in United States that focus on lead investigational drug business. Founded in 2011. They cover business area such as operator, integrin inhibition therapy, downregulate, stress, its source, all four pathway, retinal disease, diabetic macular edema, DME, nonexudative age-relate macular degeneration, ophthalmologist, ocular disease.
2011
( 13 years old in 2024 )
Lead Investigational Drug
-
31473 Rancho Viejo Road
Suite 204
San Juan Capistrano, CA 92675
United States
Private
operatorintegrin inhibition therapydownregulatestressits sourceall four pathwayretinal diseasediabetic macular edemaDMEnonexudative age-relate macular degenerationophthalmologistocular disease
* We use standard office opening hours in near Allegro Ophthalmics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Allegro Ophthalmics is Drug Discovery business from United States that founded in 2011 (13 years old in 2024), Allegro Ophthalmics business is focusing on Lead Investigational Drug.
Allegro Ophthalmics headquarter office and corporate office address is located in 31473 Rancho Viejo Road Suite 204 San Juan Capistrano, CA 92675 United States.
Allegro Ophthalmics was founded in United States.
In 2024, Allegro Ophthalmics is currently focus on lead investigational drug sector.
Above is snippet of Google Trends for "lead investigational drug" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Allegro Ophthalmics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
